ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Acasti Pharma Inc

Acasti Pharma Inc (ACST)

0.58
0.00
(0.00%)
終了 12月22日 6:00AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
0.58
買値
0.58
売値
0.98
出来高
-
0.00 日の範囲 0.00
0.58 52 週間の範囲 0.58
時価総額
前日終値
0.58
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
9,399,000
配当利回り
-
PER
-2.46
1 株当たり利益 (EPS)
-1.37
歳入
-
純利益
-12.85M

Acasti Pharma Inc について

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Jersey City, New Jersey, USA
設立
-
Acasti Pharma Inc is listed in the Pharmaceutical Preparations sector of the トロントベンチャー取引所 with ticker ACST. The last closing price for Acasti Pharma was $0.58. Over the last year, Acasti Pharma shares have traded in a share price range of $ 0.58 to $ 0.58.

Acasti Pharma currently has 9,399,000 shares in issue. The market capitalisation of Acasti Pharma is $5.45 million. Acasti Pharma has a price to earnings ratio (PE ratio) of -2.46.

ACST 最新ニュース

Acasti Pharma Reports Third Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule

LAVAL, Québec, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31

LAVAL, Québec, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18

LAVAL, Québec, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures

LAVAL, Québec, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia

LAVAL, Québec, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN)

LAVAL, Québec, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti Pharma Reports Second Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

Acasti Pharma to Present at Q4 Investor Summit

LAVAL, Québec, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022

LAVAL, Quebec, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1000.580.580.5800CS
4000.580.580.5800CS
12000.580.580.5800CS
26000.580.580.5800CS
52000.580.580.5800CS
156-0.85-59.44055944061.432.30.4737821.49992555CS
260-2.87-83.18840579713.454.050.221054680.85343966CS

ACST - Frequently Asked Questions (FAQ)

What is the current Acasti Pharma share price?
The current share price of Acasti Pharma is $ 0.58
How many Acasti Pharma shares are in issue?
Acasti Pharma has 9,399,000 shares in issue
What is the market cap of Acasti Pharma?
The market capitalisation of Acasti Pharma is CAD 5.45M
What is the 1 year trading range for Acasti Pharma share price?
Acasti Pharma has traded in the range of $ 0.58 to $ 0.58 during the past year
What is the PE ratio of Acasti Pharma?
The price to earnings ratio of Acasti Pharma is -2.46
What is the reporting currency for Acasti Pharma?
Acasti Pharma reports financial results in USD
What is the latest annual profit for Acasti Pharma?
The latest annual profit of Acasti Pharma is USD -12.85M
What is the registered address of Acasti Pharma?
The registered address for Acasti Pharma is 103 CARNEGIE CENTER, SUITE 300 PRINCETON, JERSEY CITY, NEW JERSEY, 08540
What is the Acasti Pharma website address?
The website address for Acasti Pharma is www.acastipharma.com
Which industry sector does Acasti Pharma operate in?
Acasti Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
GNFIGenifi Inc
$ 0.015
(200.00%)
4k
GHR.HGolden Harp Resources Inc
$ 0.10
(185.71%)
2.73k
TVC.HThree Valley Copper Corp
$ 0.01
(100.00%)
2k
NICKNickelex Resource Corporation
$ 0.01
(100.00%)
1.1k
GAR.HGreen Arrow Resources Inc
$ 0.045
(80.00%)
1,000
CBAChampion Bear Resources Ltd
$ 0.015
(-62.50%)
101k
NIKL.HGK Resources LTD
$ 0.045
(-50.00%)
1,000
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
3.34M
WWTWater Ways Technologies Inc
$ 0.005
(-50.00%)
106.09k
COOOstrom Climate Solutions Inc
$ 0.05
(-50.00%)
109.5k
QNCQuantum Emotion Corp
$ 0.435
(26.09%)
7.32M
GXUGoviEx Uranium Inc
$ 0.055
(10.00%)
4.68M
FUUF3 Uranium Corp
$ 0.25
(6.38%)
3.64M
AUUAALUULA Composites Inc
$ 0.05
(0.00%)
3.63M
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
3.34M

最近閲覧した銘柄

Delayed Upgrade Clock